- Home
- NXTC vs CLRO Comparison
NXTC vs CLRO Comparison
Compare NXTC & CLRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXTC
- CLRO
- Stock Information
- Founded
- NXTC 2015
- CLRO 1983
- Country
- NXTC United States
- CLRO United States
- Employees
- NXTC N/A
- CLRO N/A
- Industry
- NXTC Biotechnology: Pharmaceutical Preparations
- CLRO Radio And Television Broadcasting And Communications Equipment
- Sector
- NXTC Health Care
- CLRO Technology
- Exchange
- NXTC Nasdaq
- CLRO Nasdaq
- Market Cap
- NXTC 23.0M
- CLRO 19.8M
- IPO Year
- NXTC 2019
- CLRO N/A
- Fundamental
- Price
- NXTC $0.79
- CLRO $0.61
- Analyst Decision
- NXTC Strong Buy
- CLRO
- Analyst Count
- NXTC 2
- CLRO 0
- Target Price
- NXTC $4.00
- CLRO N/A
- AVG Volume (30 Days)
- NXTC 201.3K
- CLRO 1.1M
- Earning Date
- NXTC 11-07-2024
- CLRO 11-15-2024
- Dividend Yield
- NXTC N/A
- CLRO 81.35%
- EPS Growth
- NXTC N/A
- CLRO N/A
- EPS
- NXTC N/A
- CLRO N/A
- Revenue
- NXTC N/A
- CLRO $12,584,000.00
- Revenue This Year
- NXTC N/A
- CLRO N/A
- Revenue Next Year
- NXTC N/A
- CLRO N/A
- P/E Ratio
- NXTC N/A
- CLRO N/A
- Revenue Growth
- NXTC N/A
- CLRO N/A
- 52 Week Low
- NXTC $0.76
- CLRO $0.46
- 52 Week High
- NXTC $2.57
- CLRO $2.48
- Technical
- Relative Strength Index (RSI)
- NXTC 36.33
- CLRO 44.80
- Support Level
- NXTC $0.76
- CLRO $0.54
- Resistance Level
- NXTC $0.83
- CLRO $0.98
- Average True Range (ATR)
- NXTC 0.07
- CLRO 0.18
- MACD
- NXTC 0.01
- CLRO -0.03
- Stochastic Oscillator
- NXTC 14.87
- CLRO 8.67
About NXTC NextCure Inc.
NextCure Inc is a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. The company's product candidates include; NC410 a fusion protein of LAIR-2, a fusion protein that, in combination with pembrolizumab, demonstrated early evidence of clinical activity in colorectal (CRC) and ovarian cancers, and LNCB74, an ADC that is directed to B7-H4, a clinically validated cancer target. The company is also seeking a partner for its other clinical programs such as NC525 and NC318 and its preclinical non-oncology programs NC605, for chronic bone diseases, and NC181, for Alzheimer's disease.
About CLRO ClearOne Inc. (DE)
ClearOne Inc is a communications solutions company, which is engaged in designing, developing, and selling conferencing, collaboration, streaming, and digital signage solutions for audio, video, and visual communication. It sells its commercial products to end-users predominantly through a network of independent distributors, who in turn sell its products to dealers, systems integrators, and other resellers. Its products include DSP mixers, amplifiers, Video walls, professional cameras, and professional microphones among others. Geographically the firm has its business presence across the United States and international markets.